scout
|Articles|April 16, 2014

Special Reports

  • Melanoma (Issue 2)
  • Volume 2
  • Issue 1

An Overview of Immune Checkpoint Blockade

Jedd D. Wolchok, MD, PhD, chief, Melanoma and Immunotherapeutics Service, Lloyd J. Old Chair for Clinical Investigation, Memorial Sloan Kettering Cancer Center, explains immune checkpoint blockade.

Jedd D. Wolchok, MD, PhD, chief, Melanoma and Immunotherapeutics Service, Lloyd J. Old Chair for Clinical Investigation, Memorial Sloan Kettering Cancer Center, explains immune checkpoint blockade.

Read more about immunotherapies and combination strategies for the treatment of melanoma > >

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME